Biotech stocks are in a slump. Despite numerous wins in the high-profile areas of COVID-19 and cancer therapy, the industry...
Novavax
Credit: Pixabay/CC0 Public Domain News that the Novavax COVID-19 vaccine has shown about 60% efficacy on HIV-positive patients and that...
What happened Shares of the COVID-19 vaccine developers Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) are both marching higher today. In response...